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ABSTRACT 
 
The C. elegans postembryonic lineage, the M lineage, gives rise to mesodermal cell 
types: body wall muscles, sex muscles and coelomocytes. Past research in the Liu lab 
has shown that SMA-9, the C. elegans homolog of Drosophila Schnurri, is required 
for establishing dorsoventral asymmetry in the M lineage, and that it does so by 
antagonizing the Sma/Mab TGF-β signaling pathway. To identify additional factors 
involved in regulating dorsoventral asymmetry, our lab has screened for mutations that 
suppress the M lineage defects of sma-9 mutants. Using snip-SNP mapping, I have 
mapped one of these suppressor mutations, jj4, and identified it to be a mutation in 
Y71G12B.16, the hitherto uncharacterized C. elegans homolog of DRAGON. 
DRAGON belongs to the well-conserved RGM family of proteins, members of which 
have been shown to act as coreceptors for BMP signaling in mouse and Xenopus. 
Furthermore, I have conducted epistasis studies to place dragon in the context of the 
Sma/Mab TGF-β signaling pathway, as well as designed constructs that would help 
shed light on the temporal and spatial expression patterns of dragon. Additionally, I 
have designed and made fusion protein expression constructs, which can be used to 
generate antibodies against DRAGON.  
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CHAPTER 1 
DRAGON AND TGFβ SIGNALING IN C. ELEGANS 
 
Transforming Growth Factor β (TGFβ) signaling is a well-conserved signaling process 
in metazoans that controls a host of diverse cellular and developmental processes. In 
spite of the wide variety of processes mediated by TGFβ signaling, the signaling 
cascade is remarkably simple. The TGFβ ligand initiates signaling by recruiting type I 
and type II receptors into a heteromeric complex (Yamashita et al., 1994). The type II 
receptor phosphorylates the type I receptor, which then phosphorylates and activates 
cytoplasmic proteins called R-Smads. R-Smads bind to Co-Smads to form a complex 
that translocates into the nucleus to regulate gene transcription (reviewed in Shi and 
Massague, 2000). 
 
 
TGFβ signaling pathways in C. elegans 
 
There are two canonical TGFβ signaling pathways in C. elegans: the Sma/Mab and 
dauer pathways. Mutants in the Sma/Mab pathway have reduced body sizes (Sma) and 
male tail abnormalities (Mab), while mutants in the dauer pathway enter the dauer 
stage inappropriately under favorable environmental conditions, or fail to enter the 
dauer stage under unfavorable conditions (reviewed in Patterson and Padgett, 2000). 
In addition to its role in the regulation of body size and male tail patterning, the 
Sma/Mab TGFβ signaling pathway has also been implicated in the development of 
innate immunity in C. elegans (Nicholas and Hodgkin, 2004). It may be noted that the 
dauer stage is an alternative third larval stage, which allows C. elegans to survive 
under adverse conditions (unavailability of food, overcrowding etc). Once favorable 
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conditions return, worms can exit the dauer stage. In addition to the two canonical 
TGFβ pathways in C. elegans, there are three other TGFβ-related genes, which have 
not been placed into signaling pathways: unc-129, tig-2 and tig-3 (reviewed in Savage-
Dunn, 2005). unc-129 is involved in axonal guidance along the dorsoventral axis 
(Colavita et al., 1998), though the roles of tig-2 and tig-3 are yet to be elucidated. 
 
Signaling in the Sma/Mab TGFβ pathway is initiated by the ligand DBL-1 (Morita et 
al. and Suzuki et al., 1999). The type II receptor is encoded by daf-4 and the type I 
receptor by sma-6 (Krishna et al., 1999). The signal is transduced by Smad proteins 
SMA-2, SMA-3 and SMA-4 (Savage et al., 1996), which form a complex that 
translocates into the nucleus. Very little is known about the transcriptional cofactors 
that might interact with the Smad proteins in C. elegans to regulate gene expression, 
though SMA-9 (Liang et al., 2003) and LIN-31 (Baird and Ellazar, 1999) have been 
identified as potential cofactors. In a recent study, SMA-3 and LIN-31 have been 
shown to physically interact with each other, though no such interaction was observed 
between the Smad proteins and SMA-9 (Wang et al., 2005). Equally little is known 
about genes whose expression is regulated by the Sma/Mab TGFβ pathway. lon-1 
(Maduzia et al. and Morita et al., 2002) and sma-6 (Mochii et al., 1999) are two genes 
whose expression is regulated by TGFβ signaling, the latter providing an example of a 
positive feedback loop.  
 
The dauer TGFβ pathway utilizes a different set of Smads (DAF-3, DAF-8 and DAF-
14) and a different type I receptor (DAF-1) and ligand (DAF-7), though it shares 
DAF-4 as the common type II receptor with the Sma/Mab TGFβ pathway, DAF-4 
being the sole type II receptor in C. elegans (reviewed in Patterson and Padgett, 2000).   
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Figure 1-1: The Sma/Mab TGFβ signaling pathway (left) and the dauer TGFβ 
signaling pathway (right) - Savage-Dunn, 2005 
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Modulation of TGFβ signaling in C. elegans 
 
Since TGFβ signaling is involved in a wide range of cellular processes, it must be 
tightly regulated. In higher organisms, TGFβ signaling is regulated by such 
mechanisms as ubiquitination and subsequent degradation of Smad proteins and 
receptors (Lin et al., 2000 and Kavsak et al., 2000), use of decoy receptors such as 
BAMBI (Onichtchouk et al., 1999), use of ligand antagonists such as Noggin 
(Zimmerman et al., 1996) and control of the recruitment of Smads to the TGFβ 
receptor(s) by a protein called SARA (Tsukazaki et al., 1998). In C. elegans, none of 
the above mechanisms have been identified so far, though the genome sequence does 
reveal the presence of a SARA homolog (Patterson and Padgett, 2000). Amongst 
regulators that have been identified, LON-2, a GPI-anchored glypican protein, is 
thought to bind to the ligand DBL-1 and negatively regulate Sma/Mab TGFβ signaling 
by sequestering DBL-1 (Gumienny et al., 2007). BRA-1, a homolog of human BMP 
receptor-associated molecule BRAM1, has been shown to bind to the type I receptor 
of the dauer TGFβ pathway and negatively regulate the dauer TGFβ signaling pathway 
(Morita et al., 2001). There is also some evidence to suggest that BRA-2 (the other C. 
elegans homolog of BRAM1) and BIP (BRAM-interacting protein) might be involved 
in regulating Sma/Mab TGFβ signaling (Sugawara et al., 2001): RNAi against BIP 
resulted in a small body phenotype (Sma), phenocopying Sma/Mab TGFβ pathway 
mutants. In this thesis, I shall discuss the identification of the C. elegans homolog of a 
BMP co-receptor, DRAGON, which has been shown to potentiate BMP signaling in 
mouse and Xenopus (Samad et al., 2005). 
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CHAPTER 2 
IDENTIFICATION OF C. ELEGANS DRAGON 
 
SMA-9, the C. elegans homolog of Drosophila Schnurri, is required for establishing 
dorsoventral asymmetry in the C. elegans postembryonic mesodermal (or, M) lineage. 
The dorsal daughter of M (M.d) produces two coelomocytes and six body wall 
muscles, while the ventral daughter (M.v) produces two sex myoblasts and eight body 
wall muscles (Sulston and Horvitz, 1977). SMA-9 regulates this asymmetry by 
antagonizing the Sma/Mab TGF-β signaling pathway. sma-9 mutant animals exhibit a 
loss of the two ceolomocytes and the production of two extra sex myoblasts and body 
wall muscles on the dorsal side (Foehr et al., 2006).  
 
To identify additional factors involved in regulating this dorsoventral asymmetry, our 
lab screened for mutations that can suppress the M lineage defects of sma-9 mutants, 
i.e. restore the two M-derived ceolomocytes absent in sma-9 mutant animals. Five 
single-locus recessive suppressor mutations (jj1, jj3, jj4, jj6 and jj7) were isolated 
from the suppressor screen. When these mutations were outcrossed out of the sma-9 
background, the respective single mutants were found to have small body sizes 
(Rachel Fairbank and Amanda Lindy, unpublished data). Three of the mutations were 
characterized as being mutations in core members of the Sma/Mab TGFβ signaling 
pathway: jj1 was found to be a mutation in sma-6, jj3 a mutation in sma-3 (Foehr et 
al., 2006) and jj6 a mutation in sma-2 (Yevgeniy Plavskin, unpublished data). Of the 
uncharacterized mutations, jj4, which suppresses the sma-9 M-lineage mutant 
phenotype with a penetrance of 94% had been previously mapped to the left arm of 
chromosome I (Amanda Lindy and Yevgeniy Plavskin, unpublished data). 
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Figure 2-1: sma-9 mutations result in the loss of dorsal, and duplication of 
ventral, M lineage descendants – Foehr et al., 2006 
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The absence of known members of the Sma/Mab TGFβ signaling pathway in the 
region to which jj4 maps and its Sma phenotype indicated that jj4 might correspond to 
a new component of TGFβ signaling. Using snip-SNP mapping, followed by RNAi, I 
have been able to identify jj4 as a mutation in dragon, the C. elegans homolog of a 
well-conserved member of the TGFβ signaling pathway. 
 
 
Materials and Methods 
 
C. elegans strains: All C. elegans strains were maintained using standard methods 
(Brenner, 1974) and kept in incubators set to 110C, 140C, 160C or 200C. All strains 
containing the rrf-3 mutation were maintained at 160C. The strains referred to in 
Chapter 2 are: 
 
LW1427: N2 
LW0049: ccIs4438 (intrinsic cc::gfp) III; ayIs2(egl-15::gfp) IV; him-5(e1467) V; 
ayIs6(hlh-8::gfp) (36x) X 
LW0085: CB4856 
jj4 I; cc::gfp 
LW0058: unc-9(e101) sma-9(cc604) ayIs6(hlh-8::gfp) arIs39(cc::gfp) X 
LW0683: rrf-3(pk1426) II; ccIs4438 (intrinsic cc::gfp) III; ayIs2(egl-15::gfp) IV; 
ayIs6(hlh-8::gfp) X 
LW1525 and 1526: rrf-3(pk1426) II; ccIs4438 (intrinsic cc::gfp) III; ayIs2(egl-
15::gfp) IV; sma-9(cc604) ayIs6(hlh-8::gfp) X 
hT2[qIs48]/tm1502  
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Crosses: All crosses were set up at either 160C or 200C, and involved placing 3 - 4 L4 
hermaphrodites with 12 – 15 L4 larvae or young adult males. Cross progeny were 
collected after 4 - 5 days.  
 
Snip-SNP mapping: SNPs or single nucleotide polymorphisms are differences 
between the sequences of the Bristol (N2) and Hawaiian (CB4856) strains of C. 
elegans that exist at the level of individual nucleotides. When these SNPs can be 
distinguished in the two strains by digestion with restriction enzymes, the SNPs are 
referred to as snip-SNPs. In the case of certain snip-SNPs, the restriction enzymes that 
would have enabled us to distinguish these SNPs were not available in the laboratory 
inventory. In such situations, genomic DNA was sequenced to determine the presence 
of the SNP. It may be noted that the present study has used both snip-SNPs that have 
been identified by sequencing and restriction digestion, as well as hypothetical snip-
SNPs that I have tested and verified  
(http://genome.wustl.edu/genome/celegans/celegans_snp.cgi). In the first step of snip-
SNP mapping, jj4 hermaphrodites in the N2 background (distinguished by their small 
body size) were crossed with CB4856 males. The resulting F1 progeny were then 
allowed to self-fertilize, and F2 Sma animals collected (presumed to be homozygous 
for jj4). The latter were transferred to individual plates and allowed to self-fertilize. 
When the F2 animals had thrown a sufficient number of progeny, DNA was extracted 
from these worms. Loci containing specific SNPs were PCR-amplified from this 
DNA, and restriction digested (in case of snip-SNPs) or sequenced to check for the 
presence or absence of particular SNPs, thereby allowing one to differentiate between 
N2 and CB4856 DNA. The closer the SNPs lie to the mutation of interest (in this case, 
jj4), the less likely that these SNPs will recombine away from jj4. Thus, by scoring for 
11 
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recombinants, it is possible to follow SNPs across a chromosome and map a mutation 
to a small region. 
 
DNA for snip-SNP mapping was extracted from worms by first spraying the plates 
with sterile M9 buffer (3gm KH2PO4, 6gm Na2HPO4, 5gm NaCl and 1ml of 1M 
MgSO4 in 1 liter water, and autoclaved) from transfer pipettes, and subsequently 
transferring the liquid into 2 ml of a solution of 4% sucrose with 10mM EDTA. The 
suspension of worms was centrifuged at 3000 rpm for 2 minutes and then washed 
twice with distilled water. The resulting pellet was re-suspended in 200µl of lysis 
buffer (50mM KCl, 10mM Tris-Cl at pH 8.3, 2.5mM MgCl2, 0.45% NP40, 
0.45%Tween-20, 0.01% gelatin, 60µg/ml Proteinase K) and stored at -80˚C for one 
hour. The suspension was then incubated at 60°C for one hour to allow the Proteinase 
K in the lysis buffer to lyse the worms, and then at 95°C for 15 minutes to denature 
the Proteinase K. The C. elegans genomic DNA thus obtained was used for setting up 
PCR reactions.  
 
The PCR mix contained 2.5µl of the genomic DNA obtained by the above method, 
2.5µl of 10X PCR buffer (500mM KCl, 100mM Tris-Cl at pH 9.0, 1% Triton X-100), 
1µl of each of the two primers at concentration 25µM, 0.2µl of 10mM dNTPs, 2µl of 
25mM MgCl2, 0.5µl Taq polymerase and 15.3µl distilled water. The PCR cycling 
conditions involved an initial 2 minutes at 94˚C, followed by 46 cycles of 40 seconds 
at 94˚C, 50 seconds at the annealing temperature for the particular primer pair, and 1 
minute at 72˚C. The reaction was completed by maintaining the PCR mix for 10 
minutes at 72˚C and then holding it at 4˚C till the tubes were withdrawn from the 
machine. To distinguish between CB4856 and N2 DNA, the PCR products were 
restriction digested. Restriction digestion was carried out by adding 5µl of the PCR 
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mix to 0.3µl of restriction enzyme(s), 2µl 10X restriction enzyme buffer and distilled 
water made up to a total volume of 20µl. The restriction digests were incubated for 2 
hours at temperatures that would allow their respective restriction enzymes to act most 
optimally (250C, 370C etc.). The restriction digests were then run on a 2% agarose gel 
to separate and visualize the DNA fragments.  
 
Whenever the snip-SNP analysis involved the use of a rare enzyme that was not 
present in the laboratory inventory, or when the SNPs were not recognized by any 
restriction enzymes, the PCR fragment containing the SNP was sequenced to check for 
the presence of the SNP. For sequencing, 1µl of the PCR product purified by 
conventional gel filtration protocol was mixed with 1µl of 10µM primer and 16µl 
distilled water in sequencing tubes. The sequencing mixes were sent to the DNA 
Sequencing Facility in the Biotechnology Building of Cornell University. 
 
Identifying a mutation in a gene by sequencing: To identify a mutation in a gene, 
primers were designed at ~500bp intervals across the length of the gene in both the 5’ 
and 3’ directions. For each sequencing reaction, 1µl of the gel-purified PCR product of 
the entire gene was mixed with 1µl of 10µM primer and 16µl of distilled water and 
sent to the DNA Sequencing Facility in the Biotechnology Building of Cornell 
University. Since each sequencing reaction provides unambiguous results for 500-
700bp, one would be able to obtain a series of sequences that could be pieced together 
in both the 5’ and 3’ directions to generate the sequence of the entire gene. By 
comparing the pieced together sequence of the mutant gene with the sequence of the 
wild-type gene, one can thus identify mutations in the former. 
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Recovering cDNA from the ProQuest library: The Invitrogen C. elegans ProQuest 
cDNA library consists of cDNA fragments (of average length 1.4kb) inserted into 
vectors. I am thankful to Dave Pruyne of the Bretscher lab, who kindly provided me 
with the library as well as the ForwLong primer. In order to recover cDNA from the 
ProQuest library, a PCR was set up by mixing 0.25µl of the ProQuest library, 0.5µl 
ForwLong PC86 primer  
(5’ TATAACGCGTTTGGAATCACTACAGGGATGTTTAATACCAC 3’) at 
concentration 1µg/ml (which anneals to the vector 5’to the cDNA insert), 1µl of 25µM 
reverse primer (which anneals to the 3’ end of the cDNA), 1µl 10mM dNTPs, 0.5µl 
iProof polymerase, 10µl 5X iProof PCR buffer and 36.25µl distilled water. After 
incubating for 3 minutes at 980C, the reaction mix was cycled 10 times at 980C for 1 
minute, 650C for 1 minute and 720C for 1 minute + 1minute/kb. This was followed by 
15 cycles at 980C for 1 minute, 650C for 1 minute and 720C for 1 minute 10 seconds + 
1 minute/kb. After allowing all product extension to finish by keeping the reaction at 
720C for 10 minutes, the reaction was held at 40C till the tubes were removed from the 
machine. 5µl of the PCR product was then loaded on a 1% agarose gel to visualize the 
PCR product. cDNA could have been also recovered from the ProQuest library by 
using a primer annealing to the 5’ end of the cDNA and the RevLong PC86 primer, 
which anneals to the vector downstream of the cDNA insert. This was however not 
done in the present study because of certain difficulties I faced in obtaining the 
relevant PCR product. 
 
After recovery of cDNA from the ProQuest library, it was cloned into TOPO-Blunt II 
vector by using the Zero Blunt TOPO PCR Cloning kit from InvitrogenTM. 2µl of the 
PCR product was mixed with 1µl each of salt solution (1.2M NaCl and 0.06M MgCl2) 
and TOPO-Blunt II vector (both supplied in the Invitrogen kit), and 2µl distilled 
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water. This mix, known as the transformation mix was incubated at room temperature 
for 15 minutes. 2µl of the transformation mix was used to transform a vial of One Shot 
TOP10 chemically competent cells. The cells were incubated on ice for 10 minutes 
with the transformation mix, and then heat-shocked for 30 seconds at 420C. The cells 
were then immediately transferred to an ice bath and kept for 2 minutes. 250µl of 
sterile SOC media was added to the cells and the cells were then gently rocked at 370C 
for an hour. 20, 50 and 100µl of the SOC mix were plated onto individual LB plates 
containing 50µg/ml kanamycin and 40µl of 40mg/ml X-Gal. The plates were 
incubated at 370C overnight, and inspected for white colonies the following day. 
White colonies indicated that the ligation of the cDNA insert into the vector had been 
successful in those particular bacteria, while blue colonies indicated an unsuccessful 
ligation. Individual white colonies were used to inoculate 2ml of 2X YT broth 
containing 50µg/ml kanamycin. The tubes were shaken at 370C overnight, and the 
plasmid DNA extracted from the bacteria by a conventional Miniprep protocol. 
 
RNAi in C. elegans by micro-injection: RNAi is a process of silencing a gene at the 
mRNA level, in which double-stranded RNA triggers the degradation of a 
homologous mRNA. For conducting RNAi experiments in the present study, the 
double-stranded RNA homologous to the target mRNA was injected into the animals 
by Dr. Kelly Liu using the procedure highlighted in Fire et al. (1998). The effects of 
RNAi were observed in the progeny of the injected animals. 
 
In the first step, specific DNA sequences were PCR amplified from genomic N2 DNA 
using the same conditions outlined earlier in the section on snip-SNP mapping. RNA 
was synthesized from the PCR product by an in vitro transcription reaction, in which 
4.5µl of PCR product was mixed with 2µl 5X T7 buffer, 3µl 25mM rNTPs and 0.5µl 
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T7 RNA polymerase. The transcription reaction was allowed to go on for 3 hours at 
370C. 0.5µl of the transcribed RNA was kept aside, while the rest was purified using 
the standard phenol-chloroform extraction protocol that is used to purify PCR 
products. The final RNA pellet was resuspended in 10µl DEPC water. The purified 
RNA was run alongside the unpurified RNA on a 2% agarose gel to verify that little or 
no RNA had been lost during the purification process. Since RNA is extremely 
susceptible to degradation, care was taken to ensure that the experimental work-space 
was free of RNases. Sterility was maintained at every juncture of the experiment. The 
dsRNA thus generated was used for micro-injection. If the yield of dsRNA was 
extremely high, it was diluted 1:2 before being injected. 
 
RNAi in C. elegans by feeding: Specific genes in C. elegans can be silenced 
following the ingestion of dsRNA-expressing bacteria (Timmons and Fire, 1998). A 
genomic fragment of dragon was PCR amplified and cloned into the L4440 feeding 
vector. L4440 is a modified Bluescript vector with a T7 promoter on each side of the 
multiple cloning site driving transcription of each DNA strand. The primers used for 
the PCR amplification of dragon were DS-151 and DS-152, and after the PCR product 
was purified by standard phenol-chloroform extraction protocol, the pellet obtained 
from the latter was dissolved in 8µl distilled water. 2µl of the PCR product was 
digested at 370C with 0.3µl each of HinDIII and SpeI in 2µl NEB #2 buffer and 15.4µl 
water. 2µl of the L4440 vector was digested similarly with HinDIII, PstI and SpeI. The 
restriction digests were loaded onto a 1% agarose gel and the relevant bands cut out of 
the gel and gel purified. The pellet of the digested PCR product was dissolved in 5µl 
water, while that of the digested vector was dissolved in 7µl water. A ligation reaction 
was set up at 160C overnight by mixing 5µl of the digested PCR product with 1µl of 
the digested vector, 1µl 10X ligation buffer, 1µl T4 ligase and 2µl water. DH5α cells 
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were transformed with the ligation mix by a standard heat shock protocol and plated 
onto LB-Ampicillin plates. Single colonies from the latter were used to inoculate 2ml 
2X YT, from which plasmid DNA was extracted by a conventional Miniprep protocol. 
The feeding vector containing the dragon insert was denoted pDS11. The plasmid 
DNA was checked by restriction digestion with HinDIII and SpeI, as well as by 
sequencing. HT115(DE3) competent cells were then transformed with pDS11. 
HT115(DE3) is an RNase III-deficient Escherichia coli strain with IPTG-inducible T7 
polymerase activity (Timmons et al., 2001). As controls, competent cells were also 
transformed with the blank L4440 vector, a construct containing a fragment of sma-2 
cloned into L4440 (III-4N03) and another containing a fragment of sma-3 cloned into 
L4440 (III-3J09). The transformed bacteria were plated onto LB-Ampicillin-
Tetracyclin plates and allowed to grow overnight at 370C. Single cells were used to 
inoculate LB with 75µg/ml Ampicillin and 12.5µg/ml Tetracyclin. 200µl of this 
bacterial inoculum was used to seed each IPTG-containing NGM plate. The plates 
were allowed to dry overnight and stored at 40C.  
 
RNAi by feeding can be done with either L1 or L4 animals. In the former case, the 
phenotypes of the adult animals are observed to determine the effect of the RNAi, 
while in the latter, the effects of the RNAi are observed in the next generation. To 
obtain a synchronized population of L1 animals, gravid adults were collected in M9 
buffer. To this was added 1ml of Clorox and 1ml of 10M sodium hydroxide, with the 
final volume made up to 10ml with water. The tubes were gently shaken and allowed 
to stand for 2 minutes. The tubes were then centrifuged at 3000 rpm for 2 minutes and 
the supernatant drained off. The pellet was washed twice in water/ M9 buffer and 
finally resuspended in 1ml M9 buffer. The sodium hypochlorite in the Clorox lyses the 
worms, and since the eggs are resistant to hypochlorite treatment, one can collect the 
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eggs in the M9 buffer at the end. The eggs were allowed to hatch by gently rocking the 
tubes overnight at 160C. Since the M9 buffer contains no nutrients, the hatched larvae 
are arrested at the L1 stage. 50 - 100 L1 larvae were placed on each IPTG-NGM plate 
and the plates were kept at 160C. 
 
For carrying out RNAi by feeding L4 larvae, 4 – 6 L4 larvae were placed on each 
IPTG-NGM plate and allowed to lay eggs. When the worms had laid 50 - 100 eggs in 
total, they were transferred to another IPTG-NGM plate. The worms were allowed to 
lay eggs over a total of four IPTG-NGM plates. The plates were kept at 160C and the 
progeny observed for effects of the RNAi. 
 
 
Results and Discussion 
 
By carrying out snip-SNP mapping on a sample size of 629 worms, I mapped jj4 to an 
interval between -14.6 and -13.15 map units on chromosome I, a region spanning 231 
kb of DNA. Table 2-1 lists the primers that I had used for the purpose of mapping, 
together with the map positions of the SNPs that they amplified on chromosome I. 
 
To confirm this map location, I took two recombinant jj4 strains that I had generated 
during the course of my mapping experiments: #19, which had CB4856 DNA till -
14.5828 map units on chromosome I (and N2 DNA all the way to the right end of the 
chromosome); and #27, which had CB4856 DNA till -13.1227 map units (and N2 
DNA all the way to the left end of the chromosome). 
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Table 2-1: List of primers used for mapping jj4 with the map positions of the 
SNPs that they amplify on chromosome I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   PRIMER PAIR     LOCUS ON I    PRIMER PAIR     LOCUS ON I 
DS-9/10 -18.4361   DS-11/12 -8.11021 
       DS-13/14        -1.646        DS-15/16       -4.483 
       DS-17/18        -5.209        DS-19/20       -19.4382 
       DS-21/22       -16.7152        DS-23/24       -11.9964 
       DS-25/26       -15.3783        DS-27/28       -14.7492 
       DS-29/30       -15.3783        DS-31/32       -11.9964 
       DS-33/34       -13.1227        DS-35/36       -11.9964 
       DS-37/38       -10.5945        DS-39/40       -4.47575 
       DS-41/42       -3.90174        DS-43/44       -14.5828 
       DS-45/46       -12.3596        DS-47/48       -13.8168 
       DS-49/50       -13.1227        DS-51/52       -14.7482 
       DS-53/54       -14.669        DS-55/56       -14.6433 
       DS-57/58       -13.8168        DS-59/60       -13.1227 
       DS-61/62       -13.8168        DS-63/64       -13.8168 
       DS-65/66       -13.8168        DS-67/68       -15.3783 
       DS-117/118   -14.385        DS-119/120   -13.405 
       DS-121/122   -13.319        DS-123/124   -13.492 
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Using the series of crosses outlined in Figure 2-2, I introduced the recombinant 
chromosome I into a sma-9 unc-9 background and saw that it was able to suppress the 
sma-9 mutant phenotype, restoring the two M-derived ceolomocytes absent in sma-9 
mutant animals. Because the only N2 DNA on chromosome I that is common to both 
#19 and #27 lies between -14.5828 and -13.1227, these results suggest that the jj4 
mutation must be located in this interval.  
 
The region that I had mapped jj4 to contains 26 predicted genes. RNAi by micro-
injection in a unc-9 sma-9 mutant background was carried out by Dr. Kelly Liu against 
23 genes in this region, in order to test whether RNAi of one of these genes would 
phenocopy the suppression of the sma-9 mutant phenotype by jj4. The 3 genes at the 
periphery of this region were not included in the RNAi analysis since the results of the 
snip-SNP mapping suggested that jj4 was located in the center of the region. The list 
of these predicted genes, along with the primers that were used to amplify the genomic 
DNA for synthesizing gene-specific dsRNAs is given in Table 2-2.  
 
We found that RNAi against Y71G12B.16 resulted in a suppression of the sma-9 
mutant phenotype and was able to restore the 2 M-derived coelomocytes absent in 
sma-9 mutants with a penetrance of nearly 60%. Y71G12B.16 codes for the C. 
elegans homolog of DRAGON, a protein that has been found to act as a co-receptor 
for BMP signaling in mouse and Xenopus (Samad et al., 2005). 
 
 
 
 
 
20 
 41
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2: Cross scheme for introducing a recombinant chromosome I into a 
sma-9 unc-9 background 
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#19 jj4*      CB                       jj4          N2 
               
             -14.5828  
 
#27 jj4*      N2                       jj4          CB 
 
 
                            -13.1227 
 
 
hT2 : gfp         X        him-5    
tm1502         him-5 
    
 
 
           ht2 : gfp       X     jj4*    
       +     jj4*       
 
 
  
                          ht2 : gfp         X         sma-9 unc-9     
      jj4*                   sma-9 unc-9 
 
                (See next page)     
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Figure 2-2 (Continued) 
 
        jj4*        sma-9 unc-9    
             +         + 
 
 
 
            jj4*        sma-9 unc-9    
             +           sma-9 unc-9  
 
 
 
 
                       jj4*        sma-9 unc-9    
            jj4*        sma-9 unc-9     
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Table 2-2: List of primers used to amplify genomic DNA for synthesizing gene-
specific dsRNAs for RNAi (gene names on the left hand side of each cell) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      LOCUS               PRIMER PAIR        LOCUS           PRIMER PAIR 
Y91H12A.1           DS-99/100 Y71G12B.21        DS-89/90 
Y73E7A.3              DS-95/96 Y71G12B.33        DS-91/92 
Y73E7A.4              DS-69/70 Y71G12B.22        DS-93/94 
Y73E7A.5              DS-71/72 Y71G12B.17        DS-97/98 
Y73E7A.2              DS-73/74 Y71G12B.23        DS-101/102 
Y73E7A.6              DS-75/76 Y71G12B.16        DS-103/104 
Y73E7A.9              DS-77/78 Y71G12B.31        DS-105/106 
Y73E7A.7              DS-79/80 Y71G12B.15        DS-107/108 
Y73E7A.1              DS-81/82 Y71G12B.14        DS-109/110 
Y73E7A.8              DS-83/84 Y71G12B.13        DS-111/112 
Y71G12B.20          DS-85/86 Y71G12B.12        DS-113/114 
Y71G12B.18          DS-87/88 Y71G12B.21        DS-115/116 
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To verify the results of the RNAi by micro-injection, I also carried out RNAi by 
feeding. L1 and L4 larvae of an rrf-3(pk1426) II; ccIs4438 (intrinsic cc::gfp) III; 
ayIs2(egl-15::gfp) IV; ayIs6(hlh-8::gfp) X strain and an rrf-3(pk1426) II; ccIs4438 
(intrinsic cc::gfp) III; ayIs2(egl-15::gfp) IV; sma-9(cc604) ayIs6(hlh-8::gfp) X strain 
were fed with bacteria containing RNAi constructs for L4440, sma-2, sma-3 or 
dragon. L4440 was the negative control and sma-2 and sma-3 were the positive 
controls. It may be noted that rrf-3 mutants are hypersensitive to RNAi treatment 
(Simmer et al., 2002). 3.3% of the progeny thrown by rrf-3(pk1426) II; ccIs4438 
(intrinsic cc::gfp) III; ayIs2(egl-15::gfp) IV; ayIs6(hlh-8::gfp) X L4 larvae fed on 
L4440 were found to have a small body size(N=453), as did 26.4% of the progeny of 
L4 larvae fed on sma-2 RNAi bacteria (N=344), 37.8% of  the progeny of L4 larvae 
fed on sma-3 RNAi bacteria (N=354) and 21.7% of  the progeny of L4 larvae fed on 
dragon RNAi bacteria (N=377). Since sma-2, sma-3 and jj4 mutants are small in size, 
the results of the feeding experiment provides further evidence that jj4 is indeed a 
mutation in dragon. None of the progeny thrown by rrf-3(pk1426) II; ccIs4438 
(intrinsic cc::gfp) III; ayIs2(egl-15::gfp) IV; sma-9(cc604) ayIs6(hlh-8::gfp) X L4 
larvae fed on L4440 (N=439) were found to have 6 coelomocytes. However, 1% of the 
progeny of L4 larvae fed on sma-2 RNAi bacteria (N=386), 1.5% of the progeny of L4 
larvae fed on sma-3 bacteria (N=264) and 52.3% of the progeny of L4 larvae fed on 
dragon RNAi bacteria (N=375) were found to have 6 coelomocytes. The low 
penetrance of suppression of the sma-9 mutation by sma-2 and sma-3 RNAi could be 
due to the fact that RNAi was not efficient.  That RNAi against dragon is able to 
suppress the sma-9 mutation is encouraging since it provides us with additional proof 
that jj4 is a dragon mutant. These results also suggest that jj4 might be a loss-of-
function mutant of dragon since RNAi results in the degradation of the mRNA 
message and RNAi of dragon is able to phenocopy the jj4 mutant phenotype. 
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6% of the rrf-3(pk1426) II; ccIs4438 (intrinsic cc::gfp) III; ayIs2(egl-15::gfp) IV; 
ayIs6(hlh-8::gfp) X adults that had been fed on L4440 (N=66) since the L1 stage were 
found to be small, as were 18.7% of the adults fed on sma-2 RNAi bacteria (N=166), 
35.3% of the adults fed on sma-3 RNAi bacteria (N=116) and 25% of the adults fed on 
dragon RNAi bacteria (N=132). As noted before, jj4, sma-2 and sma-3 mutants are 
small in size, and the results of the RNAi experiment once again suggested that jj4 is a 
dragon mutant. Of the rrf-3(pk1426) II; ccIs4438 (intrinsic cc::gfp) III; ayIs2(egl-
15::gfp) IV; sma-9(cc604) ayIs6(hlh-8::gfp) X adults that had been fed on L4440 and 
sma-3 RNAi bacteria since the L1 stage, none had 6 coelomocytes (N=66 and 177, 
respectively), while 1.8% of the adults that had been fed sma-2 RNAi bacteria 
(N=164) and 39.3% of the adults that had been fed dragon RNAi bacteria (N=196) 
were found to have 6 coelomocytes. These results lend further credence to the fact that 
jj4 is indeed a mutation in dragon. 
 
In order to verify the gene annotation of Y71G12B.16 on WormBase 
(www.wormbase.org), I recovered cDNAs corresponding to the gene from the 
ProQuest C. elegans cDNA library by using the ForwLong and DS-147 primers. DS-
147 anneals to the 3’ end of Y71G12B.16 (dragon). I then sequenced the cDNAs after 
cloning them into TOPO-Blunt II vectors. Surprisingly, the start site was found to be 
1363bp upstream of that given in WormBase, and there was one additional intron, one 
additional exon and a 60bp 5’ UTR upstream of the newly annotated start site. The 
first exon was found to be 49bp long, while the first intron immediately following it 
was 1069bp in length. The start site as originally annotated on WormBase was located 
in the second exon, 185bp after the 3’ end of the first intron.   
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After proper annotation, C. elegans DRAGON was found to be a well-conserved 
protein 408 amino acids long: it shares approximately 80% amino acid identity with its 
zebrafish, human and mouse homologs. Surprisingly, there is no corresponding 
homolog in Drosophila. DRAGON has a predicted N-terminal signal peptide 
sequence, a C-terminal hydrophobic tail and a putative GPI-anchor site. I first sought 
to establish the presence of a GPI-anchor site in C. elegans DRAGON by using a GPI-
anchor prediction program available online at  
http://mendel.imp.ac.at/gpi/gpi_server.html (Eisenhaber et al., 1999). The software 
failed to predict the definite presence of a GPI-anchor site in the C. elegans DRAGON 
sequence and indicated that the most likely site of GPI-anchorage in C. elegans 
DRAGON would be a Ser residue at position 387. However, when I entered the mouse 
DRAGON sequence, the program also failed to definitively predict the presence of a 
GPI-anchor. Since it has been previously shown that DRAGON homologs contain a 
GPI-anchor site (Monnier et al., 2002; Samad et al., 2005), I can likely conclude that 
C. elegans DRAGON also contains a GPI-anchor site, notwithstanding the negative 
prediction returned by the program.  
 
DRAGON belongs to the repulsive guidance molecule (RGM) family of proteins, 
which includes such members as hemojuvelin (Babitt et al., 2006) and RGMa (Babitt 
et al., 2005) in higher organisms. Hemojuvelin is involved in iron metabolism (Babitt 
et al., 2006), while RGMa has been implicated in neuronal differentiation (Matsunaga 
et al., 2006). DRAGON is the only member of the family present in C. elegans.   
 
Finally, I sequenced the Y71G12B.16 (C. elegans dragon) locus in jj4 mutant animals 
in order to identify the molecular lesion. The list of primers used for sequencing is 
given in Table 2-3. All distances are from the start site annotated on WormBase.  
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Figure 2-3: Gene structure of C. elegans dragon showing exons and introns. The 
green boxes represent exons, while the black lines represent introns. The 5’ UTR 
is represented by the black box. The location of the molecular lesion in jj4 is 
denoted by the asterisk (*). 
 
 
 
 
 
Figure 2-4: Schematic of C. elegans DRAGON 
 
 
 
 
 
 
 
5’ 3’ 
Start site 
Start site as annotated on WormBase 5’ UTR 
* 
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Table 2-3: List of primers used to sequence the Y71G12B.16 locus (primer 
positions on the left hand side of each cell are relative to the start site annotated 
on WormBase) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    5’ PRIMER               POSITION  3’ PRIMER               POSITION 
     DS-125                  -195bp    DS-133                  ~3.4kb 
     DS-126                   217bp DS-134                   3127bp 
DS-127                   774bp DS-135                   2648bp 
 DS-128                   1232bp DS-136                   2228bp 
 DS-129                   1728bp DS-137                   1786bp 
 DS-130                   2208bp DS-138                   1347bp 
 DS-131                   2688bp    DS-139                    794bp 
DS-132                   3095bp    DS-140                    319bp 
    DS-153                    ~ -1kb    DS-158                 ~ -900bp 
    DS-154                  ~ -500bp    DS-159                 ~ -500bp 
    DS-157                  ~ -1.5kb    DS-161                 ~ -120bp 
    DS-160                  ~ -500bp  
    DS-162                  ~ -190bp  
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From the results of sequencing, jj4 is found to have a mutation in which the G at the 
start of the first intron is mutated to an A. This will likely prevent splicing of the first 
intron, and ultimately result in a truncated protein containing only the first exon. Thus, 
jj4 is probably a null mutant of C. elegans dragon.  
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CHAPTER 3 
EXPRESSION OF DRAGON cDNA TO GENERATE ANTIBODIES AGAINST 
DRAGON 
 
Generating antibodies against a protein is of paramount importance for localization 
and biochemical assays. GFP-tagging a protein to study its expression pattern, while 
convenient, has its disadvantages, the most important of which is the potential 
interference of the GFP tag with its fusion partner, thereby leading to its misfolding 
and possible mislocalization. To verify the expression patterns of a DRAGON::GFP 
fusion protein, immunostaining using antibodies against DRAGON is thus necessary. 
Additionally, the antibody can be used for biochemical assays such as Western blot 
and immunoprecipitation. 
 
 
Materials and Methods 
 
Expression of GST::DRAGON and optimizing its solubility: Two GST::DRAGON 
fusion constructs were generated by cloning a 1086 bp and a 688 bp fragment of 
DRAGON cDNA into the GST-expression vector PGEX-6P-1. Both of these 
constructs encompassed regions toward the N-terminus of the protein. The 1068bp 
sequence was immediately 3’ to the N-terminal signal peptide sequence, while the 
688bp fragment was generated by restriction digestion of the 1068bp sequence. The 
1068 bp sequence was PCR amplified from pDS9.5- a plasmid containing full-length 
dragon cDNA, by using primers DS-172 and DS-168. After checking 5µl of the PCR 
product on a 2% agarose gel, 3µl of the PCR product and 1µl of the PGEX-6P-1 
vector were restriction digested at 370Cwith 0.3µl each of EcoRI and SalI in 2µl of 
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NEB EcoRI buffer, with the final volume made up to 20µl with distilled water. 
Simultaneously, 3µl of the PCR product was restriction digested at 370C with 0.3µl 
each of EcoRI and HaeIII in NEB #2 buffer, with the final volume made up to 20µl 
with distilled water. Additionally, 1µl of the PGEX-6P-1 vector was first digested with 
0.3µl of EcoRI in 2µl of NEB EcoRI buffer and 16.7µl distilled water, and then 
digested at 250C with 0.3µl SmaI in 5µl NEB #4 buffer and 24.7µl distilled water. The 
restriction digests were loaded on a 1% agarose gel and the relevant bands cut out and 
gel-purified. The resulting DNA pellets were each dissolved in 8µl of distilled water. 
One ligation reaction was set up at 160C overnight by mixing 1µl of the resuspended 
DNA pellet of the EcoRI/SalI-digested PGEX-6P-1, 4µl of the resuspended DNA 
pellet of the similarly digested PCR product of DS-172 and DS-168., 1µl 10X ligation 
buffer, 1µl T4 ligase and 3µl distilled water. The other ligation reaction involved 
mixing 1µl of the resuspended DNA pellet of the EcoRI/SmaI-digested PGEX-6P-1, 
4µl of the resuspended DNA pellet of the EcoRI/HaeIII-digested PCR product of DS-
172 and DS-168, 1µl 10X ligation buffer, 1µl T4 ligase and 3µl distilled water. The 
former ligation reaction was used to generate pDS16, the plasmid containing GST 
fused to a 1086 bp fragment of dragon cDNA, while the latter reaction generated 
pDS17, the plasmid containing GST fused to a 688 bp fragment of dragon cDNA. 
 
The ligation mix was used to transform Escherichia coli DH5α competent cells, which 
were then plated on LB-Ampicillin plates and incubated overnight at 370C. Individual 
colonies from the plates were used to inoculate 2ml of 2X YT containing 75 µg/ml 
ampicillin, and the tubes shaken overnight at 370C. Plasmid DNA was extracted from 
these bacterial cultures by standard Miniprep protocol, and the resulting DNA pellets 
each dissolved in 15µl distilled water. After checking 1µl of the plasmid DNA by 
restriction digestion with 0.3µl of each of SalI and EcoRI in 2µl NEB EcoRI buffer 
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and 16.4µl water, and loading the digests on a 1% agarose gel, two of the samples, 
pDS16.2 and pDS17.5 were selected for expression studies. The two samples were 
also sequenced to ensure that the cDNA inserts were in frame with the rest of the 
vector. 
 
0.5µl of each prep of pDS16.2 and pDS17.5 was used to transform Escherichia coli 
BL21* competent cells. The transformed cells were plated onto LB-Ampicillin plates 
and incubated overnight at 370C. Single colonies were each used to inoculate 2ml LB-
Ampicillin and the tubes were shaken overnight at 370C. 100µl overnight culture was 
used to inoculate 4ml LB-Ampicillin, which was shaken for 3 hours at 370C. The 
optical density at 600nm (A600) was noted and the samples then induced with 1mM 
IPTG (to induce expression of the GST-fused protein), and shaken at 370C for 3 more 
hours. Prior to induction, the A600 should preferably be in the range 0.4 - 0.8. 
 
To verify that the samples had been induced properly, 1ml of each induced sample 
was spun down at 13000 rpm for 2 minutes. The pellets were resuspended in 100µl of 
ice-cold 1X PBS. 100µl of 2X SDS buffer was added and the samples boiled for 10 
minutes. The samples were then spun down for 10 minutes at 13000 rpm, and 20µl of 
each sample loaded onto 10% SDS-PAGE. The latter comprised a 10% resolving gel 
and a stacking gel. The former was created by mixing 3.75ml 40% acrylamide 
liquigel, 5ml 1.5M Tris (pH 8.8), 75µl 20% SDS, 4.15ml water, 25µl TEMED and 
75µl APS, and then pouring the mixture into gel plates to allow it to solidify. The 
stacking gel that was poured on top of the resolving gel was created by mixing 0.62ml 
40% acrylamide liquigel, 0.615ml 0.5M Tris (pH 6.8), 25µl 20% SDS, 4.025ml water, 
5µl TEMED and 50µl APS. The gel was stained with Coomassie in acetic acid and 
methanol for 30 minutes and destained in water till the protein bands were visible.  
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Upon verifying that the samples had been induced, I checked if the GST::DRAGON 
fusion proteins were being expressed in the soluble or insoluble fraction. Each colony 
of transformed BL21* bacteria was used to inoculate 5ml LB-Ampicillin, and the tubes 
were shaken overnight at 370C. 1ml of the overnight inoculum was used to inoculate 
50ml LB-Ampicillin and the A600 noted after 3 hours. The cells were then induced 
with 1mM IPTG and allowed to grow for a further 3 hours. 1ml of each culture was 
kept aside as a pre-treatment control, while the remaining cells were spun down for 10 
minutes at 10000 rpm. The resulting pellets were washed twice with ice-cold 1X PBS 
and resuspended in 1.5 - 5ml ice-cold 1X ice-cold PBS (depending on the size of the 
pellet). Sonication was carried out on the samples (6 - 8 bursts of 20 seconds each) and 
the sonicates then spun down for 10 minutes at 10000 rpm. The supernatant was 
removed and the pellets resuspended in 1 – 1.5ml ice-cold 1X PBS. 15µl of each of 
the supernatant and pellet were mixed with 15µl 2X SDS buffer and boiled for 10 
minutes. The samples were spun down at 13000 rpm for 5 minutes and loaded onto 
10% SDS-PAGE.  
 
In order to increase the solubility of the expressed fusion proteins and allow them to 
be expressed in the soluble fraction, 10 mg/ml lysozyme was added after resuspending 
the pellet prior to the sonication step. The volume of lysozyme was equal to 1/10 the 
volume of ice-cold 1X PBS added to resuspend the pellet. Additionally, Triton X-100 
was added to the sonicate after the sonication step to a final concentration of 1%. In 
order to better solublize the expressed protein, the fusion proteins were induced for 1.5 
hours instead of 3 hours, or induced at lower temperatures (300C for 6 hours and 180C 
for 12 hours), or grown for only 1 hour 40 minutes prior to induction instead of 3 
hours. 
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Extracting GST::DRAGON from inclusion bodies: Often, fusion proteins are 
expressed in the insoluble fraction in the form of inclusion bodies, which can be 
solublized by treating them with urea. After sonication and separating the supernatant 
from the pellet, and resuspending the latter in ice-cold 1X PBS, four 100µl aliquots 
were taken in separate tubes. The tubes were spun down for 10 minutes at 13000 rpm 
and the supernatant discarded. The pellets were resuspended in 100µl of 0.1M Tris-Cl 
(pH 8.5) containing varying concentrations of urea (1M, 2M, 5M and 8M). The tubes 
were spun at 13000 rpm for 10 minutes and the supernatant set aside. The pellets were 
resuspended in 50µl ice-cold 1X PBS, and both the pellets and supernatants were 
loaded onto 10% SDS-PAGE.  
 
Western Blot analysis of GST::DRAGON with antibodies against GST: In order 
to verify the identity of the overexpressed protein as GST::DRAGON, Western Blot 
analysis was carried out using an antibody against the GST tag. In the first step, 
GST::DRAGON was run on 10% SDS-PAGE using the protocol described earlier. 
The gel was not stained and destained to visualize the bands. A piece of nitrocellulose 
membrane the same size as the gel was cut and soaked in methanol for 5 seconds, and 
then in water for 5 minutes. The membrane was kept in cold transfer buffer (12gm 
Trizma base, 57.6gm glycine, 700ml methanol and 20ml 20% SDS made up to 4 liters 
with water). Two pieces of Whatman paper of the same size as the gel and membrane 
were also cut out and soaked in transfer buffer. Finally, two pieces of scotchbrite pad 
were washed with water and soaked in transfer buffer. A sandwich was made under 
the transfer buffer, where the following were assembled in the transfer cassette in the 
given order (from the black to white side of the cassette): scotchbrite pad, Whatman 
paper, gel, nitrocellulose membrane, Whatman paper, scotchbrite pad. Care was taken 
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to ensure there were no bubbles in the cassette, which was then locked and loaded 
onto the gel transfer box. An ice tray was kept in place on one side of the cassette, and 
transfer buffer was poured into the gel box. The transfer was allowed to take place at 
70V for one hour.  
 
After an hour, the cassette was removed from the apparatus and the transfer sandwich 
carefully disassembled. The nitrocellulose membrane was incubated in blocking 
solution (10% milk in 1X PBS with 0.1% Tween-20) at room temperature for one 
hour, and then washed thrice in 1X PBS with 0.1% Tween-20 (1X PBST) for 15 
minutes each. After this step, the membrane was incubated overnight at 40C (or, for an 
hour at room temperature) with goat anti-GST antibody (final concentration 1:2000) in 
10ml of a solution containing 5% milk and 0.1% Tween-20 in 1X PBS. The 
membrane was then washed thrice for 15 minutes each with 1X PBST, and incubated 
overnight at 40C (or, for an hour at room temperature) with HRP donkey anti-goat 
antibody (final concentration 1:10000 ) in 10ml of a solution containing 5% milk and 
0.1% Tween-20 in 1X PBS. The membrane was washed thrice for 15 minutes each 
with 1X PBST and drained of excess liquid by touching it to a scrap piece of 
Whatman paper. The membrane was then placed on an acetate sheet and 250µl of each 
ECL solution added to it. The membrane was covered with another acetate sheet and 
placed in a cassette. An X-ray film was placed on the acetate sheet and exposed for 
varying amounts of time. The film was developed to visualize the bands.  
 
Obtaining DRAGON antibodies by direct injection of SDS-PAGE gel pieces: 
Should the GST::DRAGON fusion protein be solublized only at high concentrations 
of urea (for example: 5M, 8M etc), it would not be possible to affinity purify the 
fusion protein using glutathione since high concentrations of urea would interfere with 
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the binding of the fusion protein to the glutathione beads. In such a case, it would be 
expedient to produce antibodies against DRAGON by excising the corresponding 
band(s) out of an SDS-PAGE gel and sending the excised band(s) to Cocalico 
Biologicals Inc. of Reamstown PA, the company from which the Liu lab usually 
obtains its antibodies. To generate antibodies in rats, 175µg of protein antigen is 
required for each animal. Since it is usually customary to send double the amount of 
protein antigen in order to be on the safe side, 350µg of protein antigen per animal 
would be a good estimate.  
 
The protein samples were first loaded onto a 10% SDS-PAGE placed in a large gel 
electrophoresis unit from Bio-Rad. The composition of the stacking and resolving gels 
were the same as before. The protein samples were allowed to run through the 
stacking gel at 11mA for 1 hour, and through the resolving gel at 20mA for 8 hours. 
The gel was stained with Coomassie in water for 10 minutes and destained in water for 
20 minutes. The bands of interest were cut out and put into tubes. The tubes were 
dipped into liquid nitrogen and stored at -800C. They were shipped to Cocalico 
Biologicals Inc. over dry ice. 
 
 
Results and Discussion 
 
pDS16.2 and pDS17.5 were both expressed robustly at their expected molecular 
weights: 68 kD and 53 kD, respectively, albeit in the insoluble fraction. Reducing the 
induction temperature to 180C or 300C, or reducing the induction time to 1.5 hours did 
not result in the protein being expressed in the soluble fraction. Reducing the growth 
period prior to induction to 1 hour 40 minutes, or treating with Triton X-100 and 
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lysozyme did not help either. The fusion proteins were extracted into the soluble 
fraction only when the insoluble fraction was washed with 8M urea, a concentration 
that would interfere with the affinity purification of the fusion proteins. As a 
consequence, I decided to cut the relevant band out of a polyacrylamide gel and 
directly send it to Cocalico Biologicals Inc.  
 
In order to verify the identity of the fusion protein, I carried out a Western Blot using 
an antibody against the GST tag of the GST::DRAGON fusion protein expressed by 
pDS17.5. 0.5, 1 and 2µl of the supernatant obtained after washing with 8M urea were 
analyzed in the Western blot. 7µl each of uninduced and induced PGEX-6P-1 vector, 
and 10µl of uninduced pDS17.5 were used as controls. The X-ray film was exposed 
for 15 minutes. 
 
From the Western Blot, one can see that the PGEX-6P-1 was induced robustly, though 
there appeared to be some nominal expression of GST in the uninduced vector as well. 
The latter can be explained by spillover from the adjacent lane. The uninduced 
pDS17.5 vector did not give a signal. The signal from 0.5µl of the 8M urea wash was 
too faint to be detected, while 1µl and 2µl of the 8M urea wash gave distinct bands. 
Surprisingly, the signal from probing 2µl of the wash was fainter than the signal from 
1µl of the wash. The expected molecular weight of the expressed GST should have 
been 26 kD and that of the expressed GST::DRAGON fusion protein 53 kD. The 
molecular weights of the bands corresponding to GST and GST::DRAGON observed 
in the Western Blot tallied closely with the expected values. 
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               (1)  (2)   (3)   (4)  (5)          (6)                 (7)    
 
 
Figure 3-1: Western Blot of expressed fusion protein using antibody against GST. 
The lanes from left to right: (1) MW marker (2) Uninduced PGEX-6P-1, (3) 
Induced PGEX-6P-1, (4) Uninduced pDS17.5, (5) 0.5µl Induced pDS17.5, (6) 1µl 
Induced pDS17.5, (7) 2µl Induced pDS17.5. The molecular weights of the marker 
bands are shown in the figure. 
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Figure 3-2: Quantifying the amount of GST::DRAGON expressed by pDS17.5.  
The lanes from left to right: (1) MW marker, (2) 1µl of a 1:10 dilution of a 8M 
urea wash of GST::DRAGON, (3) 2µl of a 1:10 dilution of a 8M urea wash of 
GST::DRAGON, (4) 5µl of a 1:10 dilution of a 8M urea wash of GST::DRAGON, 
(5) 1µl of a 8M urea wash of GST::DRAGON, (6) 2µl of a 8M urea wash of 
GST::DRAGON, (7) 5µl of 0.5 mg/ml BSA, (8) 5µl of 1 mg/ml BSA, (9) 5µl of 2 
mg/ml BSA. The molecular weights of the marker bands, expressed fusion 
protein and BSA are shown in the figure. 
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To generate anti-DRAGON antibodies in a rat, the company needed 175µg protein 
antigen per animal. Since we had decided to use two animals, and since our lab usually 
sends double the amount of protein antigen required by the company, I ran a total of 
700µg of the fusion protein expressed by pDS17.5 on a polyacrylamide gel and cut out 
the bands corresponding to the fusion protein of interest. The fusion protein expressed 
by pDS16.2 was not used to generate antibodies since its expression yield was 
considerably lower than that of pDS17.5. I quantified the amount of GST::DRAGON 
by running 1µl, 2µl and 5µl of a 1:10 dilution, and 1µl and 2µl of the supernatant 
obtained after extracting with 8M urea, along with 5µl each of 0.5 mg/ml, 1 mg/ml 
and 2 mg/ml of BSA.  
 
By comparing the intensities of the bands, I was able to determine that the 
concentration of GST::DRAGON in the supernatant obtained after washing with 8M 
urea was 2.5 mg/ml. For 700µg of GST::DRAGON, I thus needed to load 280µl of the 
supernatant obtained after washing with 8M urea. To be on the safe side, I loaded 
320µl. Once the antibody is available from Cocalico Biologicals Inc., in the first round 
of purification, the antibody could be purified against the bacterially expressed fusion 
protein bound to nitrocellulose (Smith and Fisher, 1984). In the second round of 
purification, the antibody can be further purified by pre-adsorption with extracts from 
jj4 larvae (Maloof and Kenyon, 1998). The purified antibody can then be used for 
biochemical analysis, as well as to determine the cellular localization of DRAGON. 
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CHAPTER 4 
GENERATION OF STRAINS FOR EPISTATIS ANALYSIS OF DRAGON 
 
dbl-1 codes for the ligand of the Sma/Mab TGFβ signaling pathway, while LON-2 
binds to DBL-1 and negatively regulates the Sma/Mab TGFβ signaling pathway by 
attenuating the amount of DBL-1 (Gumienny et al., 2007; Suzuki et al., 1999). sma-6 
codes for the type I receptor that receives the signal from the ligand. Both dbl-1(wk70) 
and sma-6(jj1) animals are much shorter than wild-type N2 worms, while lon-2(e678) 
animals are longer. Maduzia et al. and Morita et al. (2002) identified lon-1as a target 
of the Sma/Mab TGFβ signaling pathway. lon-1(e185) animals are longer than wild-
type N2 worms. Maduzia et al. also showed that lon-1 mRNA levels were up-
regulated in sma-6(0) animals, thus providing evidence that lon-1 is negatively 
regulated by the Sma/Mab TGFβ pathway.  
 
The jj4 mutant phenotype is characterized by a small body size, similar to that 
observed in other Sma/Mab TGFβ pathway mutants such as dbl-1(wk70) and sma-
6(jj1). In this chapter, I will discuss the generation of double mutants of jj4 with 
several other mutants in the Sma/Mab TGFβ pathway (dbl-1(wk70), ctIs40(dbl-1++), 
lon-1(e185), lon-2(e678) and sma-6(jj1)) to place jj4 in the context of the pathway.  
 
Mutations in the Sma/Mab TGFβ pathway also result in a male tail patterning defect, 
in which rays 4 and 5, 6 and 7, and 8 and 9 fuse together (Suzuki et al., 1999; Krishna 
et al., 1999; Savage-Dunn et al., 2000). It would be interesting to study the male tail in 
jj4 mutants to see if its patterning bears any similarity to that of other mutants in the 
pathway. Additionally, while conducting epistasis analysis between jj4 and other 
members of the TGFβ signaling pathway, one needs to measure the body sizes of the 
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various mutant strains. Previous work in the lab has indicated that the presence of a 
GFP transgene in a strain could affect the body size of that strain. Thus, the GFP needs 
to be removed. The following section will also discuss strategies to outcross GFP from 
strains, as well as generate a jj4 male strain. 
 
 
Materials and Methods 
  
C. elegans strains: All C. elegans strains were maintained using standard methods 
(Brenner, 1974) and kept in incubators set to 110C, 140C, 160C or 200C. The strains 
referred to in Chapter 4 are as follows: 
LW1427: N2 
LW0049: ccIs4438 (intrinsic cc::gfp) III; ayIs2(egl-15::gfp) IV; him-5(e1467) V; 
ayIs6(hlh-8::gfp) (36x) X 
LW0058: unc-9(e101) sma-9(cc604) ayIs6(hlh-8::gfp) arIs39(cc::gfp) X 
LW0614: cup-5(ar465) sma-3(jj3) III; cc::gfp 
LW1085: ccIs4438 (intrinsic cc::gfp) III; ayIs2(egl-15::gfp) IV; dbl-1(wk70) V; 
ayIs6(hlh-8::gfp) X 
LW1288: sma-6(jj1) II; cc::gfp 
BW1940 ctIs40(dbl-1++) [ZC421(+);  sur-5::gfp] X 
jj4 I; cc::gfp 
hT2[qIs48]/tm1502  
lon-1(e185) III 
lon-2(e678) X 
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Crosses: All crosses were set up at either 160C or 200C, and involved placing 3 - 4 L4 
hermaphrodites with 12 – 15 L4 larvae or young adult males. Cross progeny were 
collected after 4 - 5 days. 
 
Generating the jj4 male strain, and jj1, jj3 and jj4 without GFP: The cross schemes 
for generating a jj4 male strain and a jj4 strain without GFP are shown in Figure 4-1. It 
may be noted the presence of the him-5 mutation results in an increased frequency of 
X chromosome non-disjunction, and therefore an increased frequency of males. 
 
Generating the lon-1(e185) jj4 double mutant: Double mutants of jj4 with lon-1 
were generated in order to place jj4 in the context of the Sma/Mab TGFβ signaling 
pathway. lon-1 animals have body sizes longer than wild-type N2 worms. If jj4 were 
acting downstream of lon-1, the corresponding double mutant would have a small 
body phenotype. Should jj4 be acting upstream of lon-1, the corresponding double 
mutant would have a long body size phenotype. Conversely, if jj4 were acting in 
parallel with lon-1, the corresponding double mutant would have an intermediate body 
size phenotype. The cross scheme for generating a double mutant between jj4 and lon-
1(e185) is illustrated in Figure 4-2. 
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him-5      X   jj4     cc : gfp    
him-5      jj4     cc : gfp 
 
     
 
  him-5  jj4    cc : gfp        
      +                   +          + 
   
 
 
 
                              
him-5  jj4   +      +   jj4   +     
him-5  jj4   +               +             jj4   +  
 
 
 
Figure 4-1: Cross scheme for generating the jj4 male strain, and jj1, jj3 and jj4 
strains without GFP 
 
 
 
A similar cross scheme was used to 
generate  jj1and jj3 worms without GFP. 
48 
 69
lon-1            X            him-5    
lon-1         him-5 
          
 
 
     lon-1                  X                jj4    
        +             jj4 
 
 
 
            lon-1      jj4    OR    +      jj4    
         +          +       +  + 
 
 
 
 
  lon-1      +  
  lon-1      +  
 
  lon-1     jj4 
  lon-1     + 
   
  lon-1     jj4 
  lon-1     jj4 
 
Figure 4-2: Cross scheme for generating the lon-1(e185) jj4 double mutant 
Pick 25 worms and allow 
them to self-fertilize in 
individual plates. Of 
these 25 plates, pick 2 
plates which give all 
long (i.e. homozygous 
lon-1) progeny. Allow 
one worm from each of 
the 2 plates to self-
fertilize. 
Pick a total of 24 worms from the progeny of 
the above 2 worms. Allow the 24 worms to 
self-fertilize, and then sequence for jj4. Select 
worms that are homozygous for jj4. 
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Generating the lon-2(e678) jj4 and ctIs40(dbl-1++) jj4 double mutants: ctIs40(dbl-
1++) animals, which overexpress DBL-1 contain an integrated array of multiple 
copies of dbl-1. Both ctIs40 and lon-2(e678) animals have extended body lengths. If 
jj4 were acting downstream of lon-2 or dbl-1, the corresponding double mutant would 
have a small body phenotype. Should jj4 be acting upstream of lon-2 or dbl-1, the 
corresponding double mutant would have a long body size phenotype. Conversely, if 
jj4 were acting in parallel with lon-2 or dbl-1, the corresponding double mutant would 
have an intermediate body size phenotype. The cross scheme for generating double 
mutants between jj4 and lon-2(e678), and jj4 and ctIs40(dbl-1++) is illustrated in 
Figure 4-3. 
 
Generating the dbl-1(wk70) jj4 and sma-6(jj1) jj4 double mutants: The cross 
scheme for generating double mutants between jj4 and dbl-1(wk70), and jj4 and sma-
6(jj1) is illustrated in Figure 4-4. 
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ht2 : gfp         X        him-5    
tm1502         him-5 
    
 
           ht2 : gfp       X     lon-2     
       +     lon-2    
 
 
 ht2 : gfp      lon-2       X   jj4    
       +       jj4 
 
 
ht2 : gfp      lon-2    
    jj4            + 
 
 
ht2 : gfp      lon-2    
    jj4          lon-2 
 
 
      jj4      lon-2    
      jj4       lon-2   
 
 
Figure 4-3: Cross scheme for generating the lon-2(e678) jj4 and ctIs40(dbl-1++) 
jj4 double mutants 
A similar cross scheme was used to generate 
ctIs40(dbl-1++) jj4 double mutants 
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ht2 : gfp         X        him-5    
tm1502         him-5 
    
 
           ht2 : gfp       X     dbl-1    
       +     dbl-1    
 
 ht2 : gfp      dbl-1       X   jj4    
       +  +     jj4 
 
 
ht2 : gfp      dbl-1      OR  ht2 : gfp        +    
     jj4            +        jj4           + 
 
 
  ht2 : gfp      dbl-1    
       jj4           dbl-1 
 
 
         jj4       dbl-1    
         jj4       dbl-1 
 
 
 
Figure 4-4: Cross scheme for generating the dbl-1(wk70) jj4 and sma-6(jj1) jj4 
double mutants 
A similar cross scheme was used to 
generate sma-6 (jj1) jj4 double mutants 
52 
 73
Results and Discussion 
 
Using the cross schemes outlined in methods, I generated jj1, jj3 and jj4 strains 
without GFP. There were three isolates for each of jj1 and jj3 strains without GFP: 
1A1, 1D1 and 1D3, and 2A3, 2D3 and 2C3 respectively. The single isolate of jj4 
without GFP was 2B, while there were nine isolates of the jj4 male strain: 2B2, 2B1, 
1A1, 1B1, 1A5, 2A2, 2A1, 1A4 and 1A3. In preliminary experiments, I assessed the 
length of the double mutant worms by eye. The three isolates of the lon-1(e185) jj4 
double mutant, B4, B5 and B18 (without GFP) seemed to resemble the long lon-
1(e185) single mutant, suggesting that lon-1 might be acting downstream of jj4. The 
ctIs40(dbl-1++) jj4 and lon-2 jj4 double mutants seemed to be intermediate in size 
between the lon-2(e678) and ctIs40(dbl-1++) single mutants, and jj4. This suggests 
that jj4 might act parallel to the Sma/Mab TGFβ signaling pathway at the level of lon-
2 and dbl-1. The two isolates of the lon-2(e678) jj4 double mutant did not carry any 
GFP and were designated as AI and BIII. The two isolates of the ctIs40(dbl-1++) jj4 
double mutant, #2 and #4 carried coelomocyte GFP as well as sur-5::GFP integrated 
into the transgene array carrying multiple copies of dbl-1. The sma-6(jj1) jj4 and dbl-
1(wk70) jj4 double mutants resembled the single mutants, suggesting that jj4 might be 
acting within the Sma/Mab TGFβ pathway at the level of the receptor SMA-6 and 
ligand DBL-1. These preliminary results need to be verified by repeating the crosses 
and obtaining exact measurements of the single mutants and double mutants. The body 
sizes of the single mutants and double mutants are summarized in Table 4-1. The three 
isolates of the dbl-1(wk70) jj4 double mutant without GFP were 1A, 1B and 2A, while 
the single isolate with ceolomocyte GFP was 2B. There were three isolates apiece of 
the sma-6(jj1) jj4 double mutant with and without ceolomocyte GFP: 1C, 2B and 2C, 
and 1A, 1B and 2A respectively.  
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Table 4-1: Summary of C. elegans strain sizes used in epistasis analysis, as 
estimated by visual observation 
 
STRAIN 
 
ESTIMATED SIZE 
ctIs40(dbl-1++) 
 
LONG 
lon-1(e185) 
 
LONG 
lon-2(e678) 
 
LONG 
dbl-1(wk70) 
 
SMALL 
sma-6(jj1) 
 
SMALL 
jj4 ctIs40(dbl-1++) 
 
INTERMEDIATE 
jj4 lon-2(e678) 
 
INTERMEDIATE 
jj4 dbl-1(wk70) 
 
SMALL 
jj4 sma-6(jj1) 
 
SMALL 
jj4 lon-1(e185) 
 
LONG 
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CHAPTER 5 
GENERATION OF PLASMID CONSTRUCTS FOR TRANSGENE RESCUE 
EXPERIMENTS 
 
The RNAi and sequencing experiments described in Chapter 2 identified jj4 as a 
mutation in Y71G12B.16- the C. elegans homolog of DRAGON, a potential co-
receptor of the Sma/Mab TGFβ signaling pathway that has been shown to potentiate 
BMP signaling in mouse and Xenopus (Samad et al., 2005). In order to verify that jj4 
is indeed a mutation in dragon, a construct containing full-length dragon driven by its 
own promoter must be introduced into mutant animals in order to test for rescue of the 
mutant phenotype. Additionally, to gain further insights into the function of dragon, 
its temporal and spatial expression patterns must be determined. The former can be 
determined by expressing dragon cDNA under the control of a heat-shock promoter at 
different times in the life cycle and determining when it must be expressed for its 
proper function. The latter can be determined by a transcriptional fusion construct, 
which will shed light on the subset of cells and tissues in which DRAGON is 
expressed. One can also determine if C. elegans DRAGON needs to be expressed in 
the M lineage for its proper function by forcing its expression under the control of a 
M-lineage specific promoter. In the following section, I shall discuss the schemes for 
generating the constructs that can be used for carrying out the above experiments. 
 
 
Materials and Methods 
 
Generation of the transcriptional fusion construct: The transcriptional fusion 
construct was generated by introducing a 4kb fragment of the dragon promoter along 
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with its first exon and intron upstream of GFP containing a nuclear localization signal 
(NLS). lacZ and an unc-54 3’UTR were located downstream of the GFP. The lacZ 
moiety, on account of its large size would ensure that the expressed GFP would 
remain within the nucleus. The first exon and intron were incorporated in the construct 
since regulatory sequences are often present in the first exon and intron of C. elegans. 
ATG was removed from the first exon to prevent its translation.  
 
The 4kb promoter fragment was PCR amplified from N2 DNA by using primers DS-
163 and DS-164. 10µl of 5X iProof High GC Buffer was mixed with 0.5µl of 25µM of 
each primer, 1µl 10mM dNTPs, 0.2µl N2 DNA, 0.5µl iProof polymerase and 37.3µl 
water. The PCR mix was initially incubated for 30 seconds at 980C, and then taken 
through 30 cycles of 10 seconds at 980C, 30 seconds at 590C and 2 minutes at 720C. 
The PCR was then taken through 10 minutes at 720C and held at 40C. The PCR 
product was purified by a standard phenol-chloroform extraction protocol and the final 
pellet dissolved in 10µl water. 4µl of the latter was digested at 370C with 0.3µl of each 
of PstI and SalI, 2µl NEB #3 buffer and water made up to a final volume of 20µl. 
Concomitantly, 1µl of pPD96.04 (a gift from Dr. Andrew Fire) diluted 1:10 was also 
digested in a similar fashion. The digests were run on a 1% agarose gel and the 
relevant bands cut out and gel purified. The digested PCR product extracted from gel 
purification was dissolved in 5µl water, while the digested plasmid was dissolved in 
6µl water. A ligation reaction was set up overnight at 120C with 1µl of the digested 
plasmid, 5µl of the digested PCR product, 1µl T4 ligase, 1µl 10X ligation buffer and 
2µl water. The ligation mix was used to transform DH5α cells, which were then spread 
over LB-Ampicillin plates. Single colonies were used to inoculate 2X YT with 75 
µg/ml Ampicillin, and the plasmid DNA was extracted by standard Miniprep 
procedure. The plasmid DNA was checked both by restriction digestion as well as by 
57 
 78
sequencing. The plasmid containing 4kb of the promoter upstream of GFP, NLS, LacZ 
and unc-54 3’UTR was denoted as pDS14.  
 
DS-180 and DS-166 were used to PCR amplify the first exon (minus ATG) and intron 
from N2 DNA using a protocol similar to that used for amplifying the promoter 
fragment. However, instead of allowing the primers to anneal at 590C, annealing was 
done at 610C and the 720C extension was carried out for 1 minute 10 seconds only. 
Since the yield of the PCR product was extremely low, the PCR product was TOPO-
cloned into One Shot TOP10 competent cells using a protocol described in a previous 
section. The TOPO plasmid containing the PCR product insert was initially restriction 
digested with 0.3µl SalI, 2µl NEB #3 buffer and 16.7µl water, and then with 0.5µl 
SmaI, 5µl NEB #4 and 24.5µl water. pDS14 was also similarly digested. The 
restriction digests were loaded onto a 1% agarose gel, and the relevant bands cut out. 
The DNA was extracted from these bands and ligated as described previously. The 
ligation mix was used to transform DH5α competent cells and plasmid DNA was 
extracted by a standard Miniprep procedure. The plasmid DNA was restriction 
digested as well as sequenced to verify its identity. The transcriptional fusion construct 
containing 4kb of the promoter fragment, the first exon (minus ATG), the first intron, 
GFP, NLS, LacZ and unc-54 3’UTR was denoted as pDS15. 
 
Generation of the hlh-8p::dragon cDNA::unc-54 3’UTR construct: The construct 
containing dragon cDNA driven by the hlh-8 promoter was generated by inserting 
full-length dragon cDNA downstream of the hlh-8 promoter in the vector pJKL502 
(obtained from Dr. Kelly Liu). Full length cDNA was amplified from pDS9 by 
primers DS-169 and DS-171 by making a PCR mix containing 10µl 5X iProof Hi Fi 
Buffer, 0.5µl of 25µM of each primer, 1µl 10mM dNTPs,  1µl pDS9 diluted 1:10, 
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0.25µl iProof polymerase and 36.25µl water. The iProof PCR protocol discussed 
previously was used for the PCR, with the annealing temperature maintained at 610C 
and extension allowed for 40 seconds in each cycle. The PCR product was purified 
and the final pellet was dissolved in 10µl water. 3µl of the latter was digested with 
0.3µl each of XbaI and EcoRI in NEB #2 buffer. 1µl pJKL502 was digested similarly 
and both restriction digests loaded onto a 1% agarose gel. The relevant bands were cut 
out of the gel and the DNA gel purified from them. The digested plasmid was 
resuspended in 4µl water, while the digested PCR product was resuspended in 8µl 
water. A ligation reaction was set up as described previously with 1µl of the digested 
pJKL502 and 4µl digested PCR product. The ligation mix was used to transform 
DH5α cells, which were then plated. The plasmid DNA extracted by a conventional 
Miniprep protocol was checked by restriction digestion and sequencing. The hlh-
8p::dragon cDNA::unc-54 3’UTR construct was named pDS20. 
 
Generation of hsp-16p::dragon cDNA::unc-54 3’UTR construct: The hsp-16 
promoter is contained in a plasmid lig779 (obtained from Dr. Andrew Fire). 1µl each 
of lig779 and pDS20 were digested with 0.3µl each of HinDIII and NheI in 2µl NEB 
#2 buffer and water. The digests were loaded onto a 1% agarose gel, and the relevant 
bands were cut out and the DNA was gel purified out of the bands. 5µl of the digested 
lig779 and 1µl of the digested pDS20 were ligated as described previously. The 
ligation mix was then used to transform DH5α competent cells, which were then 
plated. The plasmid DNA extracted by the Miniprep protocol was checked by 
restriction digestion and sequencing. The plasmid containing hsp-16p::dragon 
cDNA::unc-54 3’UTR was denoted as pDS21. 
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Generation of the full-length rescue construct: The full-length rescue construct 
contains the entire ORF of dragon, 4kb of the upstream promoter sequence and 1kb of 
a downstream sequence (hypothesized to contain the 3’UTR). This DNA sequence 
was PCR-amplified out of N2 DNA. The PCR mix contained 10µl of 5X iProof Hi Fi 
Buffer, 1µl 10mM dNTPs, 0.5µl of each of DS-163 and DS-142 (at 25µM each), 0.5µl 
N2 DNA, 0.5µl iProof polymerase and 36µl water. The reaction was initially 
incubated at 980C for 30 seconds. It was then taken through 10 cycles of 10 seconds at 
980C, 30 seconds at 600C and 5 minutes at 720C. Following this, the reaction was 
taken through 20 cycles of 10 seconds at 980C, 30 seconds of 600C and 5 minutes + 20 
seconds over the previous cycle at 720C. The reaction was finished by keeping it at 
720C for 10 minutes and holding it at 40C. The PCR product was checked by running 
it on a 1% agarose gel. It was then TOPO-cloned into One Shot TOP10 chemically 
competent cells. Plasmid DNA was extracted as described in a previous section and 
checked by sequencing and restriction digestion. However, upon sequencing, it was 
discovered that there was extra T nucleotide at the 3’ end of the ORF. This plasmid 
was denoted as pDS27. To eliminate this problem, a 1201bp portion of the 3’ end of 
the ORF was excised by restriction digestion and replaced with an identical sequence 
from pDS22, which did not contain the aberrant nucleotide. pDS22, it may be noted is 
a plasmid that contains the dragon ORF and 1kb of sequence downstream of it, in a 
pJKL502 backbone. 1µl of pDS27 was first digested for 2 hours at 370C with 0.3µl 
HpaI in 2µl NEB #4 buffer and 16.7µl water, and then with 0.5µl MluI in 5µl NEB #3 
buffer and 24.5µl water. 1µl of pDS22 was also digested thus. The restriction digests 
were loaded onto a 1% agarose gel, and the relevant bands were out. The DNA was 
extracted from the bands by conventional gel purification, and the final DNA pellet 
was dissolved in 20µl in case of the digested pDS27 and 5µl in case of the digested 
pDS22. A ligation reaction was set up as described previously with 1µl of pDS27 and 
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5µl of pDS22. The ligation mix was used to transform DH5α competent cells, and the 
final plasmid that was obtained was sequenced to verify that there were no mutations 
present.  
 
 
Results and Discussion 
 
The constructs described above were all restriction digested and sequenced to verify 
their identity. These constructs will provide valuable information about the temporal 
and spatial expression patterns of C. elegans dragon. They shall be co-injected into 
gravid C. elegans adults with a plasmid pRF4 containing a dominant rol-6(su1006) 
marker (after Mello et al., 1991). Transformants can be then identified by looking for 
the roller phenotype in the progeny, induced by the presence of the rol-6 marker. 
 
With the transcriptional fusion construct, one can observe expression of GFP in the 
nuclei of various cell types, where its expression is being driven by the dragon 
promoter. Additionally, one can also observe GFP expression in different larval stages 
as well as in adult worms to check for any change in the pattern of expression over 
time.  
 
Foehr and colleagues (2006) were able to show that the antagonism between sma-9 
and the Sma/Mab TGFβ signaling pathway takes place in the M-lineage. Since dragon 
is thought to act as a co-receptor in the Sma/Mab TGFβ signaling pathway, it would 
be interesting to see if it too can suppress sma-9 when expressed specifically in the M-
lineage. This experiment can be carried out by injecting the hlh-8p::dragon 
cDNA::unc-54 3’UTR construct in sma-9 jj4 double mutants. 
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To determine what stage in the life cycle of C. elegans must dragon be expressed for 
its proper function, one can inject the hsp-16p::dragon cDNA::unc-54 3’UTR 
construct into jj4 mutants. The hsp-16 promoter can be induced by subjecting worms 
to heat shock treatment at 370C for one hour. By inducing the hsp-16 promoter at 
different stages in the life cycle of C. elegans and observing for rescue of the jj4 
mutant phenotype (i.e. small body size), one can determine the time period in which 
dragon needs to be expressed for its function of regulating body size. Conversely, the 
construct can also be injected into sma-9 jj4 double mutants, and after inducing the 
expression of dragon, one can look for reversal of the suppression of sma-9 by jj4. 
Thus, one can determine the stage at which dragon needs to be expressed in order to 
be able to suppress the sma-9 mutant phenotype. 
 
Lastly, the full-length rescue construct can be used to verify the identity of jj4 as a 
mutation in dragon. Should the full-length rescue construct be able to rescue the small 
body size phenotype of jj4 mutants, this piece of data, together with the results of the 
RNAi and sequencing experiments (discussed in the second chapter) shall definitively 
confirm jj4 to be a mutation in dragon. 
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